tirzepatide approved for teens Big update in pediatric diabetes care 🩺 Mounjaro® (tirzepatide) is now FDA- children ≥10 years old with Type 2 diabetes as an adjunct to diet and exercise. What this means ⬇️ Semaglutide Effective for Weight Loss
Description
You can count on us to make it happen
Injection technique (identical for both): Subcutaneous injection (into fat layer) Common sites: abdomen, thigh, upper arm Rotate injection sites weekly Use 4mm-6mm needle Inject slowly over 5-10 seconds Both drugs come in pre-filled pens (pharmaceutical versions) or require reconstitution (research peptides)
Weight loss is the visible outcome
Nutritional repletion remains the primary intervention
It is not a substitute for personalised medical advice
Harvard Health: Understanding New Weight Loss Drugs Mayo Clinic: Considering GLP-1 Medications
